The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

BLOCK LISTING SIX MONTHLY RETURN

10 May 2023 07:00

RNS Number : 8377Y
Omega Diagnostics Group PLC
10 May 2023
 

BLOCK LISTING SIX MONTHLY RETURN

 

Omega Diagnostics Group Plc (the "Company") provides below the information required by Schedule Six of the AIM Rules for Companies in connection with the unexercised warrants issued pursuant to the Company's capital fundraise announced 6 May 2022 ("Warrants").

 

 

Date: 10 May 2023

 

Name of applicant:

Omega Diagnostics Group PLC

Name of scheme:

Unexercised Warrants, pursuant to the Company's capital fundraise announced 6 May 2022.

Period of return:

From:

23 March 2023

To:

10 May 2023

Balance of unallotted securities under scheme(s) from previous return:

Warrants: 90,000,000 warrants over ordinary shares of 4p each ("Ordinary Shares")

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Warrants: nil

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Warrants: nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

Warrants: 90,000,000 Ordinary Shares

 

Name of contact:

Chris Lea, Company Secretary

Telephone number of contact:

020 7933 8780

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRNKCBNQBKDQPK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.